Nanjing Well Pharmaceutical Co., Ltd. announced earnings results for the nine months ended September 30, 2019. For the nine months, the company announced sales was CNY 660.725 million compared to CNY 599.908 million a year ago. Operating income was CNY 130.519 million compared to CNY 99.147 million a year ago. Net income was CNY 110.375 million compared to CNY 84.101 million a year ago. Basic earnings per share from continuing operations was CNY 1.21 compared to CNY 1.2 a year ago.